Gemma Frisius Fund logo

Gemma Frisius Fund

Europe, Vlaams-Brabant, Belgium, Leuven

Description

On July 3, 2002 the Gemma Frisius Fund II was established. Continuing the work of its predecessor Gemma Frisius Fund I, this is a venture

Investor Profile

Gemma Frisius Fund has made 34 investments, with 3 in the past 12 months and 12% as lead.

Stage Focus

  • Seed (29%)
  • Series A (26%)
  • Series B (24%)
  • Series Unknown (18%)
  • Pre Seed (3%)

Country Focus

  • Belgium (94%)
  • United Kingdom (3%)
  • France (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Chemical
  • Medical
  • Therapeutics
  • Manufacturing
  • Pharmaceutical
  • Information Technology
  • Agriculture
  • Analytics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gemma Frisius Fund frequently co-invest with?

AdBio partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
AI
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 5
VIB
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 9
Limburgse Reconversie Maatschappij
Europe, Limburg, Belgium, Hasselt
Co-Investments: 6
Innovation Fund
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3
Vives Louvain Technology Fund
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 3
KU Leuven
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 5
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 8
BF
Europe, Gelderland, The Netherlands, Gent
Co-Investments: 3
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 13

Which angels does Gemma Frisius Fund often collaborate with?

BM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
AV
Europe, Antwerpen, Belgium, Antwerp
Shared Deals: 1
CW
Europe, Vlaams-Brabant, Belgium, Leuven
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Gemma Frisius Fund?

Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AMar 24, 2025
Amount Raised: $84,139,626
Tavira Therapeutics

Teuven, Limburg, Belgium

Tavira Therapeutics develops an advanced platform that enhances AAV (adeno-associated virus) gene delivery.

BiotechnologyGeneticsTherapeutics
Pre SeedOct 1, 2024
Amount Raised: $1,106,446
Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AJun 26, 2024
Amount Raised: $18,206,938
Protealis

Gent, Oost-Vlaanderen, Belgium

Sustainable plant proteins for Europe​

AgricultureAgTechBiotechnology
Series BJan 23, 2024
Amount Raised: $23,886,612
DName-iT

Belfast, Belfast, United Kingdom

DName-iT is a genetic analysis company that offers DNA-based barcode labelling technology and a software platform.

GeneticsMedicalProductivity Tools
SeedJun 30, 2023
Amount Raised: $634,014
Dualyx

Ghent, Oost-Vlaanderen, Belgium

Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.

BiotechnologyHealth CareMedical
Series AMay 15, 2023
Amount Raised: $43,494,004
Rewind Therapeutics

Antwerp, Antwerpen, Belgium

Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.

BiotechnologyTherapeutics
Series AJan 25, 2023
MyCellHub

Leuven, Vlaams-Brabant, Belgium

MyCellHub.com - Data management and process analytics for manufacturers of cell-based products.

AnalyticsData ManagementManufacturing
Series UnknownDec 15, 2022
Amount Raised: $2,127,750
AstriVax

Heverlee, Vlaams-Brabant, Belgium

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.

Clinical TrialsMedical
SeedAug 25, 2022
Amount Raised: $29,912,416
Aphea.Bio

Zwijnaarde, Oost-Vlaanderen, Belgium

Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.

AgricultureBiotechnologyChemical
Series BApr 14, 2021
Amount Raised: $21,572,387